Arrowstreet Capital’s Amrize Ltd AMRZ Stock Holding History

Arrowstreet Capital’s Portfolio AMRZ Stock Details AMRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-274,727	Closed	-$15.3M	–	2180
2026 Q1	$15.3M	Sell	274,727 -33,464	-11%	-$1.92M	0.01%	824
2025 Q4	$16.7M	Sell	308,191 -62,735	-17%	-$3.2M	0.01%	791
2025 Q3	$18M	Buy	370,926 +293,116	+377%	+$14.9M	0.01%	765
2025 Q2	$3.87M	Buy	+77,810	New	+$3.93M	﹤0.01%	1257

Other funds holding AMRZ

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital's AMRZ Position: Q2 2026 in Review

Arrowstreet Capital sold out of Amrize Ltd (AMRZ) in Q2 2026, closing a stake of 274,727 shares — an estimated $15.3M sold.

Arrowstreet Capital first reported a position in AMRZ in Q2 2025 and held it in 4 quarters. The position peaked at $18M in Q3 2025. 464 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

Arrowstreet Capital reported no remaining Amrize Ltd position as of Q2 2026 after selling out during the quarter.
Arrowstreet Capital sold 274,727 Amrize Ltd shares in Q2 2026, an estimated $15.3M.
Arrowstreet Capital first reported a position in Amrize Ltd in Q2 2025 and held it in 4 quarters.
Arrowstreet Capital's Amrize Ltd position peaked at $18M in Q3 2025.
464 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.